Canada Pension Plan Investment Board
MCRB icon

Canada Pension Plan Investment Board’s Seres Therapeutics MCRB Stock Holding History

Canada Pension Plan Investment Board’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-40
Closed -$5K – 1382
2019
Q1 		$5K Buy
+40
New +$4.88K ﹤0.01% 1456

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Canada Pension Plan Investment Board's MCRB Position: Q2 2019 in Review

Canada Pension Plan Investment Board sold out of Seres Therapeutics (MCRB) in Q2 2019, closing a stake of 40 shares — an estimated $5K sold.

Canada Pension Plan Investment Board first reported a position in MCRB in Q1 2019 and held it in 1 quarter. The position peaked at $5K in Q1 2019. 91 funds tracked by Wall St. Rank hold MCRB as of Q2 2019.

  • Canada Pension Plan Investment Board reported no remaining Seres Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 40 Seres Therapeutics shares in Q2 2019, an estimated $5K.
  • Canada Pension Plan Investment Board first reported a position in Seres Therapeutics in Q1 2019 and held it in 1 quarter.
  • Canada Pension Plan Investment Board's Seres Therapeutics position peaked at $5K in Q1 2019.
  • 91 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2019.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2019, filed 12 Aug 2019.